Equine botulism and acute pasture myodystrophy: New soil-borne emerging diseases in Switzerland?

Schweizer Archiv fur Tierheilkunde

Volumn 148, Issue 10, 2006, Pages 553-559

  Gerber, V ^a,b   Straub, R ^a   Frey, J ^a  

^a VETSUISSE FACULTY UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Clostridia; Horse; Paralysis; Rhabdomyolysis; Toxin

Indexed keywords

ANIMALIA; CLOSTRIDIA; CLOSTRIDIUM BIFERMENTANS; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM SORDELLII; EQUIDAE; EQUUS CABALLUS;

BACTERIAL VACCINE; BOTULINUM TOXIN;

ANIMAL; ANIMAL DISEASE; ANIMAL FOOD; ANIMAL MUSCULAR DYSTROPHY; ARTICLE; BIOSYNTHESIS; BOTULISM; CLOSTRIDIUM BOTULINUM; COMMUNICABLE DISEASE; HORSE; HORSE DISEASE; MICROBIOLOGY; PATHOGENICITY; STANDARD; SWITZERLAND;

ANIMAL FEED; ANIMALS; BACTERIAL VACCINES; BOTULINUM TOXINS; BOTULISM; CLOSTRIDIUM BOTULINUM; COMMUNICABLE DISEASES, EMERGING; HORSE DISEASES; HORSES; MUSCULAR DYSTROPHY, ANIMAL; SOIL MICROBIOLOGY; SWITZERLAND;

EID: 33750104508     PISSN: 00367281     EISSN: None     Source Type: Journal    
DOI: 10.1024/0036-7281.148.10.553     Document Type: Article

References (25)

1. Barbier J., Popoff M.R., Molgó J.: Degeneration and regeneration of murine neuromuscular junctions after intramuscular injection with a sublethal dose of Clostridium sordellii lethal toxin. Infect. Immun. 2004, 72: 3120-3128.
2. Böhnel H., Gessler F.: Clostridia and clostridioses. FEMS Immunol. Med. Microbiol. 1999, 24: 4.
3. Boog C., Ramseyer A., Widmer A., Straub R., Doherr M., Herholz C., Wampfler B., Burger D. and Gerber V.: Benefits of feeding haylage instead of hay for upper and lower airway health in horses affected with inflammatory airway disease. Proceedings of the World Equine Airways Symposium, Cornell, 2005.
4. Brandt K., Hinrichs U., Glitz F., Landes E., Schulze C., Deegen E., Pohlenz J., Coenen M.: Atypische Myoglobinurie der Weideperde. Pferdeheilk. 1997, 13: 27-34.
5. Breidenbach M.A., Brunger A.T.: New insights into clostridial neurotoxin-SNARE interactions. Trends Mol. Med. 2005, 11: 377-381.
6. Byrne M.P., Smith L.A.: Development of vaccines for prevention of botulism. Bioch. 2000, 82: 955-966.
7. Clayton M.A., Clayton J.M., Brown D.R., Middlebrook J.L.: Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli. Infect. Immun. 1995, 63: 2738-2742.
8. Delguste C., Cassart D., Baise E., Linden A., Schwarzwald C., Feige K., Sandersen C., Rollin F., Amory H.: Myopathies atypiques chez les chevaux au pré:une série de cas en Belgique. Ann. Méd. Vét. 2002, 146: 235-248.
9. Dietz B.: Botulismus beim Pferd - Ein Fallbericht. Pferdeheilk. 1998, 14: 373-376.
10. Duchesnes C., Mainil J.: Molecular genetics, classification, pathology and ecology of the genus Clostridium. Presses de la Faculté de Médecine Vétérinaire de l'Université de Liège, Liège, 2002.
11. Duchesnes C., Mainil J., Peck M., Granum P.E.: Food microbiology and sporulation of the genus Clostridium. Presses de la Faculté de Médecine Vétérinaire de l'Université de Liège, Liège, 2004.
12. Gehlen H., Straub R., Ohnesorge B.: Atypische Weidemyopathie - eine bakterielle Toxikose? Pferdeheilkunde Forum - Berliner Fortbildungstage, 2005.
13. Gerber V., Straub R.: Therapie der Typhlocolitis des adulten Pferdes. Prakt. Tierarzt. 2006, 87: 120-124.
14. Hunter L.C., Poxton I.R.: Systemic antibodies to Clostridium botulinum type C: do they protect horses from grass sickness (dysautonomia)? Equine Vet. J. 2001, 33: 547-553.
15. Hosie B.D., Gould P.W., Hunter A.R., Low J.C., Munro R., Wilson H.C.: Acute myopathy in horses at grass in east and south east Scotland. Vet. Rec. 1986, 119: 444-449.
16. Longstreth W.T. Jr., Meschke J.S., Davidson S.K., Smoot L.M., Smoot J.C., Koepsell T.D.: Hypothesis: a motor neuron toxin produced by a clostridial species residing in gut causes ALS. Med Hypotheses 2005; 64: 1153-6.
17. Popoff M.R.: Entérotoxines bactériennes: structure, mode d'action et approche vaccinale. Revue Méd. Vét. 1996, 147: 425-438.
18. Popoff M.R.: Molecular biology of clostridial neurotoxins. In: Protein toxins of the genus Clostridium and vaccination. Eds. C. Duchesnes J. Mainil, M. Popoff, R. Titball, Proceedings, 22nd-23rd November 2002. Presses de la Faculté de Médecine Vétérinaire de l'Université de Liège, Liège (Belgique), 2003, 25-44.
19. Schiavo G., Matteoli M., Montecucco C.: Neurotoxins affecting neuroexocytosis. Physiol. Rev. 2000, 80: 717-766.
20. Tavallaie M., Chenal A., Gillet D., Pereira Y., Manich M., Gibert M., Rafffestin S., Popoff M.R., Marvaud J.C.: Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies. FEBS Lett. 2004, 572: 299-306.
21. Tsukamoto K., Kohda T., Mukamoto M., Takeuchi K., Ihara H., Saito M., Kozaki S.: Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipids. Novel insights into the receptor for clostridial neurotoxins. J. Biol. Chem. 2005, 280: 35164-35171.
22. Votion D.M., Delguste C., Amory H.: La myopathie atypique des équidés: particularités cliniques, examens complémentaires et hypothèses étiologiques. In: Proceedings of «Journée AVEF», 2003, 244: 254.
23. Vouret-Craviari V., Grall D., Flatau G., Pouyssegur J., Boquet P., Van Obberghen-Schilling E.: Effects of cytotoxic necrotizing factor 1 and lethal toxin on actin cytoskeleton and VE-cadherin localization in human endothelial cell monolayers. Infect. Immun. 1999, 67: 3002-3008.
24. Whitwell K.E., Harris P., Farrington P.G.: Atypical myoglobinuria: an acute myopathy in grazing horses. Equine Vet. J. 1988, 20: 357-363.
25. Wollanke B.: Botulismus in einem Bestand mit 16 Pferden und Ponys. Prakt. Tierarzt. 2004, 85: 252-261.